VESICARE Side Effects

6809854-2 | Agitation, Confusional State, Psychotic Behaviour, Restlessness
on Jun 15, 2010 Female patient from UNITED KINGDOM , 70 years of age, was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, confusional state, psychotic behaviour, restlessness. Vesicare dosage: . Patient was hospitalized.

6788786-2 | Cervicobrachial Syndrome, Dry Mouth
Patient was taking Vesicare (View Usage). Patient had the following side effects: cervicobrachial syndrome, dry mouth on Jun 10, 2010 from UNITED STATES Additional patient health information: Male patient , 82 years of age, was diagnosed with hypertonic bladder and. Vesicare dosage: 5 Mg, /d, Oral. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), GABAOENTIN (GABAPENTIN) (View Gabaoentin (gabapentin) Review and Gabaoentin (gabapentin) Label ), REQUIP (View Requip Review and Requip Label ), NAMENDA (View Namenda Review and Namenda Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.

6783322-9 | Dizziness, Dysstasia, Hypotension, Renal Failure Acute, Sluggishness
Adverse event was reported on Jun 08, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 5 Mg, Uid/qd, Oral) was diagnosed with hypertonic bladder and. Location: JAPAN , 77 years of age, weighting 131.4 lb, After Vesicare was administered, patient had the following side effects: dizziness (What is dizziness?), dysstasia, hypotension, renal failure acute, sluggishness. During the same period patient was treated with LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), STOGAR (LAFUTIDINE) TABLET (View Stogar (lafutidine) Tablet Review and Stogar (lafutidine) Tablet Label ), SENNOSIDE (SENNOSIDE A+B) (View Sennoside (sennoside A+b) Review and Sennoside (sennoside A+b) Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6781503-1 | Abdominal Distension
on Jun 02, 2010 Female patient from UNITED KINGDOM , 56 years of age, was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension. Vesicare dosage: 5mg, D.


6776255-5 | Disease Recurrence, Mitral Valve Incompetence, Urinary Incontinence
on Jun 04, 2010 Female patient from UNITED STATES , 78 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?) and was treated with Vesicare (View Usage). Patient had the following side effects: disease recurrence, mitral valve incompetence, urinary incontinence (What is urinary incontinence?). Vesicare dosage: 10 Mg, Uid/qd, Oral; 5 Mg, Uid/qd, Oral. During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ), CELEBREX (View Celebrex Review and Celebrex Label ), NEXIUM IV (View Nexium Iv Review and Nexium Iv Label ). Patient was hospitalized.

6763946-5 | Cervicobrachial Syndrome, Dry Mouth
Patient was taking Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: cervicobrachial syndrome, dry mouth on May 29, 2010 from UNITED STATES Additional patient health information: Male patient , 82 years of age, was diagnosed with hypertonic bladder and. Vesicare dosage: 5 Mg Unk/d Oral. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), REQUIP (View Requip Review and Requip Label ), NAMENDA (View Namenda Review and Namenda Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.

6757880-4 | Atrioventricular Block Second Degree, Cardiac Pacemaker Insertion, Sinus Bradycardia, Syncope
Adverse event was reported on Jun 04, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 5 Mgm Qd Po) was diagnosed with hypertonic bladder, pelvic prolapse and. Location: UNITED STATES , 92 years of age, weighting 110.0 lb, Patient experienced the following unwanted or unexpected effects: atrioventricular block second degree, cardiac pacemaker insertion, sinus bradycardia, syncope. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOVAZA (View Lovaza Review and Lovaza Label ), VIT D (View Vit D Review and Vit D Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ), SENNA (View Senna Review and Senna Label ). Patient was hospitalized.

6745122-5 | Asthenia, Blood Sodium Decreased
on May 10, 2010 Male patient from UNITED STATES , 75 years of age, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient had the following side effects: asthenia, blood sodium decreased. Vesicare dosage: 10 Mg, /d,oral. During the same period patient was treated with DESMOPRESSIN ACETATE (View Desmopressin Acetate Review and Desmopressin Acetate Label ). Patient was hospitalized.

6742458-9 | Decreased Appetite, Dysstasia, Hypotension, Renal Failure Acute
on May 13, 2010 Female patient from JAPAN , 77 years of age, weighting 131.4 lb, was diagnosed with hypertonic bladder, micturition urgency and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: decreased appetite, dysstasia, hypotension, renal failure acute. Vesicare dosage: 5mg, Uid/qd, Oral. During the same period patient was treated with LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ), LIPITOR (ATORVASTATIN CALCIUM) TABLET, 10 MG (View Lipitor (atorvastatin Calcium) Tablet, 10 Mg Review and Lipitor (atorvastatin Calcium) Tablet, 10 Mg Label ), STOGAR (LAFUTIDINE) TABLET (View Stogar (lafutidine) Tablet Review and Stogar (lafutidine) Tablet Label ), SENNOSIDE (SENNOSIDE A+B) (View Sennoside (sennoside A+b) Review and Sennoside (sennoside A+b) Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6740747-5 | Heart Valve Incompetence, Urinary Incontinence
Patient was taking Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: heart valve incompetence, urinary incontinence (What is urinary incontinence?) on May 13, 2010 from UNITED STATES Additional patient health information: Female patient , 78 years of age, was diagnosed with bladder operation and. Vesicare dosage: 10 Mg, /d, Oral; 5 Mg, /d, Oral. During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ), CELEBREX (View Celebrex Review and Celebrex Label ), NEXIUM IV (View Nexium Iv Review and Nexium Iv Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6739962-6 | Cough, Pulmonary Fibrosis
Adverse event was reported on May 12, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 62 years of age, Patient had the following side effects: cough, pulmonary fibrosis (What is pulmonary fibrosis?). Patient was hospitalized.

6735476-8 | Asthenia, Fall, Fracture, Hypoaesthesia, Muscular Weakness
on May 13, 2010 Female patient from JAPAN , 77 years of age, was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: asthenia, fall (What is fall?), fracture (What is fracture?), hypoaesthesia, muscular weakness. Vesicare dosage: 5mg, /d Oral. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), AMOBAN (ZOPICLONE) (View Amoban (zopiclone) Review and Amoban (zopiclone) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), MAGNESIUM OXIDE (MAGNESIUM OXIDE) (View Magnesium Oxide (magnesium Oxide) Review and Magnesium Oxide (magnesium Oxide) Label ), AMARYL (View Amaryl Review and Amaryl Label ), SHAKUYAKUKANZOUTOU (HERBAL EXTRACT NOS) (View Shakuyakukanzoutou (herbal Extract Nos) Review and Shakuyakukanzoutou (herbal Extract Nos) Label ), METHYCOBAL (MECOBALAMIN) (View Methycobal (mecobalamin) Review and Methycobal (mecobalamin) Label ). Patient was hospitalized.

6710212-X | Tardive Dyskinesia
on Apr 21, 2010 Male patient from UNITED STATES , 86 years of age, was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: tardive dyskinesia. Vesicare dosage: Oral. During the same period patient was treated with STATIN (View Statin Review and Statin Label ).

6693396-1 | Abdominal Discomfort, Bladder Disorder, Chest Pain, Hyperhidrosis, Hypertonic Bladder, Intestinal Functional Disorder, Pain In Extremity, Skin Disorder
Patient was taking Vesicare (View Usage). Patient had the following side effects: abdominal discomfort, bladder disorder, chest pain (What is chest pain?), hyperhidrosis, hypertonic bladder, intestinal functional disorder, pain in extremity, skin disorder on Apr 12, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 20 years of age, was diagnosed with bladder discomfort, hypertonic bladder and. Vesicare dosage: 10 Mg, Uid/qd, Oral. During the same period patient was treated with ISPAGHULA HUSK (PLANTAGO OVATA HUSK) (View Ispaghula Husk (plantago Ovata Husk) Review and Ispaghula Husk (plantago Ovata Husk) Label ).

6691385-4 | Cardiac Failure
Adverse event was reported on Apr 07, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 65 years of age, After Vesicare was administered, patient had the following side effects: cardiac failure. Patient was hospitalized.

6687641-6 | Anxiety, Bipolar Disorder, Condition Aggravated, Insomnia
on Apr 06, 2010 Female patient from DENMARK , 29 years of age, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), bipolar disorder (What is bipolar disorder?), condition aggravated, insomnia. Vesicare dosage: 10 Mg, Uid/qd, Oral. During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), SINGULAIR (View Singulair Review and Singulair Label ), FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LYSANTIN (ORPHENADRINE HYDROCHLORIDE) (View Lysantin (orphenadrine Hydrochloride) Review and Lysantin (orphenadrine Hydrochloride) Label ), SEREVENT (View Serevent Review and Serevent Label ). Patient was hospitalized.

6686915-2 | Anaemia
on Apr 05, 2010 Female patient from JAPAN , 53 years of age, weighting 127.0 lb, was diagnosed with hypertonic bladder, rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Vesicare (View Usage). Patient had the following side effects: anaemia. Vesicare dosage: 5mg Uid/qd, Oral. During the same period patient was treated with ETODOLAC (200 Mg, Uid/qd, Oral) (View Etodolac Review and Etodolac Label ), CYTOTEC (200ug, Uid/qd, Oral) (View Cytotec Review and Cytotec Label ), PREDNISOLONE TAB (1.75 Mg, Qid, Oral) (View Prednisolone Tab Review and Prednisolone Tab Label ), ACTEMRA (Iv, Nos) (View Actemra Review and Actemra Label ). Patient was hospitalized.

6686470-7 | Abnormal Behaviour, Enuresis, Hip Arthroplasty, Malignant Melanoma, Sleep Talking, Somnambulism
Patient was taking Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: abnormal behaviour, enuresis, hip arthroplasty, malignant melanoma, sleep talking, somnambulism on Apr 06, 2010 from UNITED STATES Additional patient health information: Male patient , 76 years of age, . Vesicare dosage: 10 Mg, Uid/qd, Oral. During the same period patient was treated with DAYPRO (View Daypro Review and Daypro Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), MOBIC (View Mobic Review and Mobic Label ), STOOL SOFTENER (View Stool Softener Review and Stool Softener Label ), LORTAB (PARACETAMOL, PROMETHIAZINE HYDROCHLORIDE) (View Lortab (paracetamol, Promethiazine Hydrochloride) Review and Lortab (paracetamol, Promethiazine Hydrochloride) Label ), AMBIEN (View Ambien Review and Ambien Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), NAPROXEN (View Naproxen Review and Naproxen Label ).

6680967-1 | Blood Potassium Decreased, Blood Pressure Increased, Dehydration, Malaise, Pain, Vomiting
Adverse event was reported on Apr 13, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 10 Mg I Believe One Tablet Daily Po) was diagnosed with urinary incontinence (What is urinary incontinence?) and. Location: UNITED STATES , 57 years of age, weighting 205.0 lb, Patient experienced the following unwanted or unexpected effects: blood potassium decreased, blood pressure increased, dehydration, malaise, pain (What is pain?), vomiting. Patient was hospitalized.

6676348-7 | Alopecia, Colitis Ulcerative, Constipation, Weight Decreased
on Apr 01, 2010 Female patient from UNITED STATES , 66 years of age, was treated with Vesicare (View Usage). Patient had the following side effects: alopecia, colitis ulcerative, constipation (What is constipation?), weight decreased. Vesicare dosage: 10 Mg, Oral 5 Mg, Oral. During the same period patient was treated with MULTIVITAMIN (VITAMIN NOS) (View Multivitamin (vitamin Nos) Review and Multivitamin (vitamin Nos) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6674259-4 | Delirium, Incontinence
on Mar 31, 2010 Male patient from JAPAN , 82 years of age, weighting 105.4 lb, was diagnosed with benign prostatic hyperplasia and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: delirium, incontinence. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with AMITRIPTYLINE HCL (10 Mg, Uid/qd, Oral) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MAGMITT (MAGNESIUM OXIDE) (View Magmitt (magnesium Oxide) Review and Magmitt (magnesium Oxide) Label ), SLOW K (View Slow-k Review and Slow-k Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LASIX (View Lasix Review and Lasix Label ), PLETAL (View Pletal Review and Pletal Label ). Patient was hospitalized.

6673813-3 | Condition Aggravated, Gastrointestinal Ulcer Haemorrhage, Urinary Incontinence
Patient was taking Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, gastrointestinal ulcer haemorrhage, urinary incontinence (What is urinary incontinence?) on Mar 29, 2010 from UNITED STATES Additional patient health information: Female patient , 76 years of age, was diagnosed with incontinence and. Vesicare dosage: 10 Mg, Uid/qd, Oral. During the same period patient was treated with NEXIUM IV (View Nexium Iv Review and Nexium Iv Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), CITRACAL (CALCIUM CITRATE) (View Citracal (calcium Citrate) Review and Citracal (calcium Citrate) Label ), VITAMIN D NOS (VITAMIN D NOS) (View Vitamin D Nos (vitamin D Nos) Review and Vitamin D Nos (vitamin D Nos) Label ), ACTOSE (PIOGLITAZONE HYDROCHLORIDE) (View Actose (pioglitazone Hydrochloride) Review and Actose (pioglitazone Hydrochloride) Label ), QUINAPRIL (QUNIAPRIL) (View Quinapril (quniapril) Review and Quinapril (quniapril) Label ).

6672057-9 | Renal Failure Acute
Adverse event was reported on Mar 26, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 5 Mg, /d, Oral) was diagnosed with hypertonic bladder, micturition urgency and. Location: JAPAN , 77 years of age, Patient had the following side effects: renal failure acute. During the same period patient was treated with LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), STOGAR (LAFUTIDINE) (View Stogar (lafutidine) Review and Stogar (lafutidine) Label ), SENNOSIDE (SENNOSIDE A+B) (View Sennoside (sennoside A+b) Review and Sennoside (sennoside A+b) Label ). Patient was hospitalized.

6668935-7 | Bladder Cancer, Treatment Noncompliance
on Mar 24, 2010 Male patient from UNITED STATES , 73 years of age, was diagnosed with pollakiuria and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: bladder cancer (What is bladder cancer?), treatment noncompliance. Vesicare dosage: 5 Mg D, Oral.

6666843-9 | Abnormal Behaviour, Delirium, Memory Impairment, Restlessness, Speech Disorder, Urinary Incontinence
on Mar 23, 2010 Male patient from JAPAN , 82 years of age, weighting 105.4 lb, was diagnosed with benign prostatic hyperplasia and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, delirium, memory impairment, restlessness, speech disorder, urinary incontinence (What is urinary incontinence?). Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with AMITRIPTYLINE HCL (10 Mg, Uid/qd, Oral) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), FAMOTIDINE (FAMOTIDINE) TABLET (View Famotidine (famotidine) Tablet Review and Famotidine (famotidine) Tablet Label ), MAGMIT (MAGNESIUM OXIDE) TABLET (View Magmit (magnesium Oxide) Tablet Review and Magmit (magnesium Oxide) Tablet Label ), SLOW K (View Slow-k Review and Slow-k Label ), HARNAL (TAMSULOSIN) ORODISPERSIBLE CR TABLET (View Harnal (tamsulosin) Orodispersible Cr Tablet Review and Harnal (tamsulosin) Orodispersible Cr Tablet Label ), AMLODIPINE (AMLODIPINE BESILATE) ORODISPERSIBLE CR TABLET (View Amlodipine (amlodipine Besilate) Orodispersible Cr Tablet Review and Amlodipine (amlodipine Besilate) Orodispersible Cr Tablet Label ), LASIX (View Lasix Review and Lasix Label ), PLETAL (View Pletal Review and Pletal Label ). Patient was hospitalized.

6651748-X | Fall, Muscular Weakness
Patient was taking Vesicare (View Usage). Patient had the following side effects: fall (What is fall?), muscular weakness on Mar 15, 2010 from JAPAN Additional patient health information: Male patient , 78 years of age, . Vesicare dosage: 5 Mg, /d , Oral. During the same period patient was treated with URIE (SILODOSIN) (View Urie (silodosin) Review and Urie (silodosin) Label ). Patient was hospitalized.

6649766-0 | Arthropod Bite, Dysuria
Adverse event was reported on Mar 11, 2010 by a Male patient taking Vesicare (View Usage) (Dosage: 5 Mg, Uid/qd, Oral) was diagnosed with hypertonic bladder and. Location: UNITED STATES , 92 years of age, After Vesicare was administered, patient had the following side effects: arthropod bite, dysuria. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), COSOPT (TIMOLOL MALEATE) (View Cosopt (timolol Maleate) Review and Cosopt (timolol Maleate) Label ), NEXIUM IV (View Nexium Iv Review and Nexium Iv Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ZOCOR (View Zocor Review and Zocor Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6649257-7 | Aortic Dissection, Cardiac Tamponade, Low Cardiac Output Syndrome, Myocardial Infarction
on Mar 16, 2010 Female patient from KOREA, REPUBLIC OF , 67 years of age, weighting 158.7 lb, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: aortic dissection, cardiac tamponade, low cardiac output syndrome, myocardial infarction. Vesicare dosage: 5 Mg,/d, Oral. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (CLOPIDOFREL) (View Clopidogrel (clopidofrel) Review and Clopidogrel (clopidofrel) Label ), CILOSTAZOL (CILOSTAZOL) (View Cilostazol (cilostazol) Review and Cilostazol (cilostazol) Label ).

6642515-1 | Anaemia
on Mar 09, 2010 Female patient from JAPAN , 53 years of age, weighting 127.0 lb, was diagnosed with hypertonic bladder, rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Vesicare (View Usage). Patient had the following side effects: anaemia. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with ETODOLAC (200 Mg, Uid/qd, Oral) (View Etodolac Review and Etodolac Label ), CYTOTEC (200 Ug, Uid/qd, Oral) (View Cytotec Review and Cytotec Label ), PREDNISOLONE TAB (1.75 Mg, Qid, Oral) (View Prednisolone Tab Review and Prednisolone Tab Label ), ACTEMRA (Iv Nos) (View Actemra Review and Actemra Label ). Patient was hospitalized.

6639845-6 | No Adverse Event
Patient was taking Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: no adverse event on Mar 05, 2010 from JAPAN Additional patient health information: Male patient , 89 years of age, . Vesicare dosage: 2.5 Mg/d, Oral. During the same period patient was treated with ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), FLIVAS (NAFTOPIDIL) (View Flivas (naftopidil) Review and Flivas (naftopidil) Label ), PLAVIX (View Plavix Review and Plavix Label ).

6638416-5 |
Adverse event was reported on Mar 05, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 5 Mg, Oral) was diagnosed with hypertonic bladder and. Location: KOREA, REPUBLIC OF , 67 years of age, . During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CILOSTAZOL (CILOSTAZOL) (View Cilostazol (cilostazol) Review and Cilostazol (cilostazol) Label ).

6637613-2 | Pruritus, Rash Pustular
on Jan 08, 2010 Male patient from UNITED STATES , 92 years of age, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient had the following side effects: pruritus, rash pustular. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), COSOPT (TIMOLOL MALEATE) (View Cosopt (timolol Maleate) Review and Cosopt (timolol Maleate) Label ), NEXIUM IV (View Nexium Iv Review and Nexium Iv Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ZOCOR (View Zocor Review and Zocor Label ).

6637434-0 | Cognitive Disorder, Dementia, Flushing
on Mar 03, 2010 Female patient from JAPAN , 83 years of age, was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: cognitive disorder, dementia (What is dementia?), flushing. Vesicare dosage: Oral.

6635982-0 | Visual Impairment
Patient was taking Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: visual impairment on Mar 03, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 69 years of age, weighting 106.9 lb, was diagnosed with hypertonic bladder and. Vesicare dosage: 5 Mg, Oral. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ROSIGLITAZONE (View Rosiglitazone Review and Rosiglitazone Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLICLAZIDE (GLICLAZIDE) (View Gliclazide (gliclazide) Review and Gliclazide (gliclazide) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ).

6635981-9 | Agranulocytosis, Febrile Neutropenia, Inflammation
Adverse event was reported on Mar 02, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 5 Mg, Uid/qd, Oral) was diagnosed with hypertonic bladder and. Location: JAPAN , 85 years of age, weighting 119.0 lb, Patient had the following side effects: agranulocytosis, febrile neutropenia, inflammation. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PERSANTIN (View Persantin Review and Persantin Label ), MELBURAL (EICOSAPENTAENOIC ACID ETHYL ESTER) (View Melbural (eicosapentaenoic Acid Ethyl Ester) Review and Melbural (eicosapentaenoic Acid Ethyl Ester) Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), GOSHAJINKIGAN (HERBAL EXTRACT NOS) (View Goshajinkigan (herbal Extract Nos) Review and Goshajinkigan (herbal Extract Nos) Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ALINAMIN F (FURSULTIAMINE HYDROCHLORIDE) (View Alinamin-f (fursultiamine Hydrochloride) Review and Alinamin-f (fursultiamine Hydrochloride) Label ).

6632258-2 | Asthenia, Constipation, Dizziness, Hot Flush, Uterine Dilation And Curettage
on Feb 25, 2010 Female patient from UNITED STATES , 86 years of age, was diagnosed with bladder disorder and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: asthenia, constipation (What is constipation?), dizziness (What is dizziness?), hot flush, uterine dilation and curettage. Vesicare dosage: 10 Mg, Uid/qd, Oral; Oral. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ZOCOR (View Zocor Review and Zocor Label ), VITAMIN D NOS (VITAMIN D NOS) (View Vitamin D Nos (vitamin D Nos) Review and Vitamin D Nos (vitamin D Nos) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6632257-0 | Anuria, Bladder Disorder, Constipation, Nocturia
on Feb 24, 2010 Female patient from UNITED STATES , 81 years of age, was diagnosed with incontinence and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, bladder disorder, constipation (What is constipation?), nocturia. Vesicare dosage: 5 Mg, Qod, Oral; 10 Mg, Oral. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), AVAPRO (View Avapro Review and Avapro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), NORVASC (View Norvasc Review and Norvasc Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ), CHOLEST OFF (SITOSTEROL) (View Cholest-off (sitosterol) Review and Cholest-off (sitosterol) Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ).

6631051-4 | Loss Of Consciousness
Patient was taking Vesicare (View Usage). Patient had the following side effects: loss of consciousness on Jan 20, 2010 from UNITED STATES Additional patient health information: Female patient , 79 years of age, was diagnosed with hypertonic bladder, pain (What is pain?), sleep disorder (What is sleep disorder?) and. Vesicare dosage: Oral. During the same period patient was treated with ANALGESICS () (View Analgesics () Review and Analgesics () Label ), HYPNOTICS AND SEDATIVES () (View Hypnotics And Sedatives () Review and Hypnotics And Sedatives () Label ), AMBIEN (View Ambien Review and Ambien Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ULTRACET (View Ultracet Review and Ultracet Label ).

6631037-X | Gastrooesophageal Reflux Disease, Oesophageal Spasm
Adverse event was reported on Feb 27, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: Unk, Oral) was diagnosed with pollakiuria and. Location: UNITED STATES , 61 years of age, After Vesicare was administered, patient had the following side effects: gastrooesophageal reflux disease, oesophageal spasm. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ESTRATEST H.S. (View Estratest H.s. Review and Estratest H.s. Label ), BUPROPION HYDROCHLORIDE (View Bupropion Hydrochloride Review and Bupropion Hydrochloride Label ), VITAMIN D NOS (VITAMIN D NOS) (View Vitamin D Nos (vitamin D Nos) Review and Vitamin D Nos (vitamin D Nos) Label ), CRANBERRY POWDER CAPSULES (CRANBERRY POWDER CAPSULES) CAPSULE (View Cranberry Powder Capsules (cranberry Powder Capsules) Capsule Review and Cranberry Powder Capsules (cranberry Powder Capsules) Capsule Label ). Patient was hospitalized.

6627001-7 | Chest Pain, Nausea, Panic Attack
on Feb 26, 2010 Female patient from UNITED STATES , 39 years of age, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), nausea (What is nausea?), panic attack. Vesicare dosage: 5mg, Oral. During the same period patient was treated with CONTRACEPTIVES NOS (View Contraceptives Nos Review and Contraceptives Nos Label ), PROVIGIL (View Provigil Review and Provigil Label ), CELEBREX (View Celebrex Review and Celebrex Label ).

6626710-3 | Ileus
on Feb 23, 2010 Male patient from JAPAN , 89 years of age, was treated with Vesicare (View Usage). Patient had the following side effects: ileus. Vesicare dosage: 2.5 Mg, Oral. During the same period patient was treated with ADALAT L (NIFEDIPINE) PER ORAL NOS (View Adalat L (nifedipine) Per Oral Nos Review and Adalat L (nifedipine) Per Oral Nos Label ), ALDACTONE (SPIRONOLACTONE) PER ORAL NOS (View Aldactone (spironolactone) Per Oral Nos Review and Aldactone (spironolactone) Per Oral Nos Label ), FLIVAS (NAFTOPIDIL) PER ORAL NOS (View Flivas (naftopidil) Per Oral Nos Review and Flivas (naftopidil) Per Oral Nos Label ), PLAVIX (CLOPIDOGREL SULFATE) PER ORAL NOS (View Plavix (clopidogrel Sulfate) Per Oral Nos Review and Plavix (clopidogrel Sulfate) Per Oral Nos Label ).

6626679-1 | Intestinal Obstruction
Patient was taking Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: intestinal obstruction on Feb 24, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, was diagnosed with hypertonic bladder, benign prostatic hyperplasia and. Vesicare dosage: 2.5mg, /d, Oral. During the same period patient was treated with HARNAL (TAMSULOSIN) ORODISPERSIBLE CR TABLET (0.2 Mg, /d, Oral) (View Harnal (tamsulosin) Orodispersible Cr Tablet Review and Harnal (tamsulosin) Orodispersible Cr Tablet Label ), EVIPROSTAT (CHIMAPHILA UMBELLATA, EQUISETUM ARVENSE, MANGANESE CHLORID (View Eviprostat (chimaphila Umbellata, Equisetum Arvense, Manganese Chlorid Review and Eviprostat (chimaphila Umbellata, Equisetum Arvense, Manganese Chlorid Label ). Patient was hospitalized.

6620275-8 | Condition Aggravated, Pain, Vaginal Prolapse, Vaginal Ulceration
Adverse event was reported on Feb 22, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 5 Mg, Uid/qd, Oral) was diagnosed with bladder disorder and. Location: UNITED STATES , 77 years of age, Patient experienced the following unwanted or unexpected effects: condition aggravated, pain (What is pain?), vaginal prolapse, vaginal ulceration.

6619303-5 | Blood Albumin Decreased, Nephrotic Syndrome, Renal Function Test Abnormal
on Feb 24, 2010 Female patient from JAPAN , 88 years of age, was diagnosed with pollakiuria and was treated with Vesicare (View Usage). Patient had the following side effects: blood albumin decreased, nephrotic syndrome, renal function test abnormal. Vesicare dosage: 5 Mg, /d, Oral. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), NEURELARK (TIAPRIDE HYDROCHLORIDE) (View Neurelark (tiapride Hydrochloride) Review and Neurelark (tiapride Hydrochloride) Label ), ARICEPT (View Aricept Review and Aricept Label ).

6614658-X | Dementia, Flushing
on Feb 19, 2010 Female patient from JAPAN , 83 years of age, was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: dementia (What is dementia?), flushing. Vesicare dosage: Oral.

6614562-7 | Activities Of Daily Living Impaired, Confusional State, Memory Impairment
Patient was taking Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, confusional state, memory impairment on Mar 04, 2010 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 133.0 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), neurogenic bladder and. Vesicare dosage: 10 Mg 1/day Oral.

6612759-3 | Bradycardia, Carotid Artery Occlusion, Cerebral Artery Embolism, Coma, Condition Aggravated, Monoplegia, Sick Sinus Syndrome, Wheezing
Adverse event was reported on Feb 17, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 5 Mg, Uid/qd, Oral) was diagnosed with hypertonic bladder and. Location: JAPAN , 92 years of age, weighting 110.2 lb, Patient had the following side effects: bradycardia, carotid artery occlusion, cerebral artery embolism, coma, condition aggravated, monoplegia, sick sinus syndrome, wheezing. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FERROMIA (FEROUS SODIUM CITRATE) (View Ferromia (ferous Sodium Citrate) Review and Ferromia (ferous Sodium Citrate) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NIZATIDINE (NIZATIDINE) CAPSULES (View Nizatidine (nizatidine) Capsules Review and Nizatidine (nizatidine) Capsules Label ). Patient was hospitalized.

6611015-7 | Atrial Fibrillation
on Feb 15, 2010 Male patient from UNITED KINGDOM , 58 years of age, weighting 180.8 lb, was diagnosed with bladder obstruction and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), IPRATROPIUM BROMIDE W/SALBUTAMOL (IPRATROPIUM BROMIDE, SALBUTAMOL) (View Ipratropium Bromide W/salbutamol (ipratropium Bromide, Salbutamol) Review and Ipratropium Bromide W/salbutamol (ipratropium Bromide, Salbutamol) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GLYCERYL TRINITRATE (GLYCERYL TRINITRATE) (View Glyceryl Trinitrate (glyceryl Trinitrate) Review and Glyceryl Trinitrate (glyceryl Trinitrate) Label ), SALBUTAMOL (SALBUTAMOL) (View Salbutamol (salbutamol) Review and Salbutamol (salbutamol) Label ). Patient was hospitalized.

6610906-0 | Blood Albumin Decreased, Protein Urine Present, Renal Function Test Abnormal
on Feb 12, 2010 Female patient from JAPAN , 88 years of age, was diagnosed with pollakiuria and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, protein urine present, renal function test abnormal. Vesicare dosage: 5 Mg, Oral.

6607930-0 | Chest Pain, Nausea
Patient was taking Vesicare (View Usage). Patient had the following side effects: chest pain (What is chest pain?), nausea (What is nausea?) on Feb 12, 2010 from UNITED STATES Additional patient health information: Female patient , 39 years of age, . Vesicare dosage: .